Latest Headlines

Latest Headlines

PPD deepens its Japanese focus with new joint venture leadership

PPD hired a general manager to help grow its Japan-focused joint venture with Shin Nippon Biomedical Laboratories, snagging a Parexel International veteran as it works to expand its presence in a growing market for clinical development services.

PPD signs a pair of federal deals for battlefield health, flu readiness

Privately held CRO PPD scored two federal contracts tasking it with helping to improve health outcomes for active-duty soldiers and aiding with the government's stockpile of flu vaccines.

PPD partners up to better track trial events

PPD has reached out to clinical trial software provider Cisys LifeSciences to get its hands on technology the company believes can improve the process by which investigators examine and adjudicate safety events.

Novartis, PPD conduct clinical pilot study using medical device connectivity via a smartphone app

Startup Clinical Ink said that it's in the midst of a pilot clinical study that incorporates medical device data that's collected through a smartphone app with biopharma Novartis and contract research organization PPD. The trial incorporates medical device connectivity that's provided by Clinical Ink and powered by Qualcomm's 2net Mobile Platform.

PPD strings together a site network for pediatric trials

PPD, angling to stand out among CROs running pediatric trials, has cemented a network of 8 global sites to accelerate the process of starting studies on kids.

PPD partners up for real-world outcomes research

As regulators and payers place increasing importance on real-world data, CRO PPD is working to expand its reach in the field, joining forces with a division of insurance giant Anthem.

PPD reaches into China with a new central lab

PPD has opened a new central lab facility in Shanghai, expanding its testing services into China as it stretches out around the globe.

PPD sets off in Japan with SNBL joint venture

PPD and partner Shin Nippon Biomedical Laboratories have hit the ground running with their Japanese joint venture, closing a deal that will see them join forces in the country's growing market for clinical trials.

PPD's X-Chem flips some potential drugs to partner Navitor

X-Chem, PPD's in-house biotech company, struck a deal with pioneering startup Navitor Pharmaceuticals, outlicensing some early-stage compounds discovered with its proprietary technology.

PPD cozies up to trial site group with an eye on enrollment

PPD's Acurian subsidiary has expanded its relationship with the Society for Clinical Research Sites, a group representing thousands of trial outposts around the globe, focusing on improving patient recruitment.